Cytopenia resulting from chemotherapy and other cancer treatments, is associated with morbidity/ mortality, and may negatively impact cancer outcomes.

​

The development of therapeutic Hematopoietic Growth Factors has been one of the most impactful contributions to cancer care.

​

In this presentation we will discuss the approach to cytopenia and the current understanding of appropriate use of growth factors in cancer patients. 

​

-----

​

Presentation: Gerald A Soff MD​​

     University of Miami Health System

Hanny Al-Samkari, M.D.

     Massachusetts General Hospital

Date: March 31, 2022